Diagnostic criteria for dementia in clinical trials. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines

P Antuono; R Doody; S Gilman; J Huff; P Scheltens; K Ueda; Z S Khachaturian

Diagnostic criteria for dementia in clinical trials. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines

Alzheimer Dis Assoc Disord. 1997:11 Suppl 3:22-5.

Authors

P Antuono¹, R Doody, S Gilman, J Huff, P Scheltens, K Ueda, Z S Khachaturian

Affiliation

¹ Department of Neurology, Baylor College of Medicine, Houston, Texas, USA.

PMID: 9305510

Abstract

Some of the issues associated with standardizing the diagnosis of dementia in clinical trials are outlined. Deliberations of the Working Group on Diagnostic Criteria and their recommendations for future actions needed to develop a consensus are described.

MeSH terms

Alzheimer Disease / diagnosis*
Alzheimer Disease / drug therapy
Alzheimer Disease / etiology
Clinical Trials as Topic
Dementia / diagnosis*
Dementia / drug therapy
Dementia / etiology
Geriatric Assessment / statistics & numerical data
Humans
International Cooperation*
Nootropic Agents / therapeutic use
Practice Guidelines as Topic
Reference Standards
Risk Factors

Substances

Nootropic Agents